Next 10 |
2024-07-02 08:07:59 ET Viatris’ ( NASDAQ: VTRS ) Mylan unit is no longer a subject of DOJ’s antitrust investigation in the generic drug industry, the pharmaceutical firm said on Tuesday.... Read the full article on Seeking Alpha For further details see:...
U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation PR Newswire PITTSBURGH , July 2, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that the Antitrust Divisi...
2024-06-30 00:30:00 ET Summary The S&P 500's strong first half, with gains exceeding 15%, has pushed its valuation even higher. Four stocks in the S&P 500 have a lower earnings multiple than the 4.9 percentage point gap between the average and median multiple of the index&...
Viatris Named to TIME's World's Most Sustainable Companies 2024 List PR Newswire PITTSBURGH , June 25, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has been named to the inaugural edition of TIME's W...
2024-06-25 10:29:34 ET More on S&P 500 Index: Odds For A Soft Landing Improve S&P 6300? Is That Outside The Realm Of Possibility? Nervous Calm Hangs Over The Markets Nasdaq, S&P, Dow are mixed after selloff in tech stocks Is the Nvidia-led...
2024-06-22 12:45:00 ET With the 2024 U.S. presidential elections heating up next week in the form of the first debate, Goldman Sachs' portfolio strategy research team took a look at American companies which have the biggest exposure to domestic and international sales.... Read the ful...
2024-06-15 14:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-14 12:44:17 ET More on Regeneron Pharmaceuticals Regeneron Pharmaceuticals, Inc. (REGN) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript) Regeneron Pharmaceuticals, Inc. (REGN) Management presents at Jefferies 2024 Global Healthcare Conference (Tran...
2024-06-13 12:38:50 ET Summary Viatris presents a unique equation to prospective investors. The stock is cheap on a price to sales / price to earnings ratio, but the business has been shrinking. Debt is massive - but cash flow is strong, and divestitures have already earned &g...
2024-06-11 18:03:08 ET Viatris Inc. (VTRS) Goldman Sachs 45th Annual Global Healthcare Conference June 11, 2024 09:20 AM ET Company Participants Scott Smith - CEO Theodora Mistras - CFO Philippe Martin - Chief R&D Officer Conference Call Participants ...
News, Short Squeeze, Breakout and More Instantly...
U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation PR Newswire PITTSBURGH , July 2, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that the Antitrust Divisi...
Viatris Named to TIME's World's Most Sustainable Companies 2024 List PR Newswire PITTSBURGH , June 25, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has been named to the inaugural edition of TIME's W...
2024-06-15 14:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...